Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Edgewise Therapeutics granted inducement stock options for 266,000 shares to 9 new non-executive employees on April 30, 2026. The options have an exercise price of $30.96 per share, equal to the closing price on the grant date, and vest over four years with a one-year cliff.
Key figures
- Offering Price
- 30.96
- Shares Offered
- 266000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.